G S Alexopoulos1, K Manning2, D Kanellopoulos1, A McGovern1, J K Seirup1, S Banerjee3, F Gunning1. 1. Department of Psychiatry,Weill Cornell Medical College,White Plains,NY,USA. 2. Department of Psychiatry,University of Connecticut Health Center,Farmington,CT,USA. 3. Department of Public Health,Weill Cornell Medical College,New York,NY,USA.
Abstract
BACKGROUND: Executive processes consist of at least two sets of functions: one concerned with cognitive control and the other with reward-related decision making. Abnormal performance in both sets occurs in late-life depression. This study tested the hypothesis that only abnormal performance in cognitive control tasks predicts poor outcomes of late-life depression treated with escitalopram. METHOD: We studied older subjects with major depression (N = 53) and non-depressed subjects (N = 30). Executive functions were tested with the Iowa Gambling Test (IGT), Stroop Color-Word Test, Tower of London (ToL), and Dementia Rating Scale - Initiation/Perseveration domain (DRS-IP). After a 2-week placebo washout, depressed subjects received escitalopram (target daily dose: 20 mg) for 12 weeks. RESULTS: There were no significant differences between depressed and non-depressed subjects on executive function tests. Hierarchical cluster analysis of depressed subjects identified a Cognitive Control cluster (abnormal Stroop, ToL, DRS-IP), a Reward-Related cluster (IGT), and an Executively Unimpaired cluster. Decline in depression was greater in the Executively Unimpaired (t = -2.09, df = 331, p = 0.0375) and the Reward-Related (t = -2.33, df = 331, p = 0.0202) clusters than the Cognitive Control cluster. The Executively Unimpaired cluster (t = 2.17, df = 331, p = 0.03) and the Reward-Related cluster (t = 2.03, df = 331, p = 0.0433) had a higher probability of remission than the Cognitive Control cluster. CONCLUSIONS: Dysfunction of cognitive control functions, but not reward-related decision making, may influence the decline of symptoms and the probability of remission of late-life depression treated with escitalopram. If replicated, simple to administer cognitive control tests may be used to select depressed older patients at risk for poor outcomes to selective serotonin reuptake inhibitors who may require structured psychotherapy.
RCT Entities:
BACKGROUND: Executive processes consist of at least two sets of functions: one concerned with cognitive control and the other with reward-related decision making. Abnormal performance in both sets occurs in late-life depression. This study tested the hypothesis that only abnormal performance in cognitive control tasks predicts poor outcomes of late-life depression treated with escitalopram. METHOD: We studied older subjects with major depression (N = 53) and non-depressed subjects (N = 30). Executive functions were tested with the Iowa Gambling Test (IGT), Stroop Color-Word Test, Tower of London (ToL), and Dementia Rating Scale - Initiation/Perseveration domain (DRS-IP). After a 2-week placebo washout, depressed subjects received escitalopram (target daily dose: 20 mg) for 12 weeks. RESULTS: There were no significant differences between depressed and non-depressed subjects on executive function tests. Hierarchical cluster analysis of depressed subjects identified a Cognitive Control cluster (abnormal Stroop, ToL, DRS-IP), a Reward-Related cluster (IGT), and an Executively Unimpaired cluster. Decline in depression was greater in the Executively Unimpaired (t = -2.09, df = 331, p = 0.0375) and the Reward-Related (t = -2.33, df = 331, p = 0.0202) clusters than the Cognitive Control cluster. The Executively Unimpaired cluster (t = 2.17, df = 331, p = 0.03) and the Reward-Related cluster (t = 2.03, df = 331, p = 0.0433) had a higher probability of remission than the Cognitive Control cluster. CONCLUSIONS: Dysfunction of cognitive control functions, but not reward-related decision making, may influence the decline of symptoms and the probability of remission of late-life depression treated with escitalopram. If replicated, simple to administer cognitive control tests may be used to select depressed older patients at risk for poor outcomes to selective serotonin reuptake inhibitors who may require structured psychotherapy.
Authors: Faith M Gunning-Dixon; Michael Walton; Janice Cheng; Jessica Acuna; Sibel Klimstra; Molly E Zimmerman; Adam M Brickman; Matthew J Hoptman; Robert C Young; George S Alexopoulos Journal: J Affect Disord Date: 2010-05-07 Impact factor: 4.839
Authors: Sarah Shizuko Morimoto; Faith M Gunning; Dora Kanellopoulos; Christopher F Murphy; Sibel A Klimstra; Robert E Kelly; George S Alexopoulos Journal: Int J Geriatr Psychiatry Date: 2011-05-25 Impact factor: 3.485
Authors: Sarah Shizuko Morimoto; Faith M Gunning; Christopher F Murphy; Dora Kanellopoulos; Robert E Kelly; George S Alexopoulos Journal: Am J Geriatr Psychiatry Date: 2011-02 Impact factor: 4.105
Authors: D A Seminowicz; H S Mayberg; A R McIntosh; K Goldapple; S Kennedy; Z Segal; S Rafi-Tari Journal: Neuroimage Date: 2004-05 Impact factor: 6.556
Authors: Conor Liston; Ashley C Chen; Benjamin D Zebley; Andrew T Drysdale; Rebecca Gordon; Bruce Leuchter; Henning U Voss; B J Casey; Amit Etkin; Marc J Dubin Journal: Biol Psychiatry Date: 2014-02-05 Impact factor: 13.382
Authors: R Scott Mackin; J Craig Nelson; Kevin Delucchi; Patrick Raue; Amy Byers; Deborah Barnes; Derek D Satre; Kristine Yaffe; George S Alexopoulos; Patricia A Arean Journal: Am J Geriatr Psychiatry Date: 2013-11-16 Impact factor: 4.105
Authors: Faith M Gunning; Janice Cheng; Christopher F Murphy; Dora Kanellopoulos; Jessica Acuna; Matthew J Hoptman; Sibel Klimstra; Shizuko Morimoto; James Weinberg; George S Alexopoulos Journal: Int J Geriatr Psychiatry Date: 2009-08 Impact factor: 3.485
Authors: Yuen-Siang Ang; Roselinde Kaiser; Thilo Deckersbach; Jorge Almeida; Mary L Phillips; Henry W Chase; Christian A Webb; Ramin Parsey; Maurizio Fava; Patrick McGrath; Myrna Weissman; Phil Adams; Patricia Deldin; Maria A Oquendo; Melvin G McInnis; Thomas Carmody; Gerard Bruder; Crystal M Cooper; Cherise R Chin Fatt; Madhukar H Trivedi; Diego A Pizzagalli Journal: Biol Psychiatry Date: 2020-04-23 Impact factor: 13.382
Authors: Jo Anne Sirey; Alexandra Woods; Nili Solomonov; Lauren Evans; Samprit Banerjee; Paula Zanotti; George Alexopoulos; Helen C Kales Journal: Am J Geriatr Psychiatry Date: 2020-04-23 Impact factor: 4.105
Authors: Dora Kanellopoulos; Victoria Wilkins; Jimmy Avari; Lauren Oberlin; Lindsay Arader; Merete Chaplin; Samprit Banerjee; George S Alexopoulos Journal: Am J Geriatr Psychiatry Date: 2020-01-25 Impact factor: 4.105
Authors: Rita Pasion; Ana R Gonçalves; Carina Fernandes; Fernando Ferreira-Santos; Fernando Barbosa; João Marques-Teixeira Journal: Front Psychol Date: 2017-10-11
Authors: Nili Solomonov; Jihui Lee; Samprit Banerjee; Christoph Flückiger; Dora Kanellopoulos; Faith M Gunning; Jo Anne Sirey; Conor Liston; Patrick J Raue; Thomas D Hull; Patricia A Areán; George S Alexopoulos Journal: Mol Psychiatry Date: 2020-07-10 Impact factor: 15.992